Good assessment. PAA have a lot of things coming up in terms of grants, beginning of the trial and acceptance into the Healey platform. But the 2 I'm looking forward to in order of importance are .
- OLE quarterly updates, the next one may be a bit soon to see anything significant, but the 2nd quarter will be the one. If all 10 or a majority continue to be stable, it may be enough to trigger a deal or takeover.
- The pre clinical lab results for Parkinson's and Alzheimer's. The CEO has already advised BP have been consulted on what they would like to see. Having a second bite at the cherry on top of ALS/MND will add to Monepantels attractiveness.
But as you correctly point out the market can be unpredictable.
The market may also take a little while to become completely comfortable with the recent board renewal as well, if I was watching from a distance I would also be cautious.
Cheers
- Forums
- ASX - By Stock
- PAA
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-736
-
- There are more pages in this discussion • 205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $99.65M |
Open | High | Low | Value | Volume |
19.5¢ | 20.5¢ | 19.5¢ | $95.38K | 475.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 135256 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 79851 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 135256 | 0.200 |
9 | 87953 | 0.195 |
13 | 840004 | 0.190 |
12 | 226560 | 0.185 |
18 | 352803 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 79851 | 3 |
0.210 | 269460 | 5 |
0.215 | 103895 | 2 |
0.220 | 506039 | 7 |
0.225 | 420666 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |